Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis
- 10 March 2008
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 314 (5), 1105-1114
- https://doi.org/10.1016/j.yexcr.2007.11.004
Abstract
No abstract availableFunding Information
- Cancer Research UK (C5/A4318)
This publication has 38 references indexed in Scilit:
- K-ras Mutations in Non-Small-Cell Lung Carcinoma: A ReviewClinical Lung Cancer, 2006
- Germline Missense Mutations Affecting KRAS Isoform B Are Associated with a Severe Noonan Syndrome PhenotypeAmerican Journal of Human Genetics, 2006
- The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging miceExperimental Cell Research, 2006
- Ras signaling from plasma membrane and endomembrane microdomainsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Replacement of K‐Ras with H‐Ras supports normal embryonic development despite inducing cardiovascular pathology in adult miceEMBO Reports, 2005
- K-Ras Regulates the Steady-state Expression of Matrix Metalloproteinase 2 in FibroblastsJournal of Biological Chemistry, 2003
- RAS oncogenes: the first 30 yearsNature Reviews Cancer, 2003
- SmgGDS displays differential binding and exchange activity towards different Ras isoformsOncogene, 2002
- Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genesGenes & Development, 2001
- Four Human Ras Homologs Differ in Their Abilities to Activate Raf-1, Induce Transformation, and Stimulate Cell MotilityJournal of Biological Chemistry, 1999